Patents Assigned to Innovet Italia S.r.l.
-
Patent number: 11744840Abstract: The present invention relates to an N-palmitoyl-D-glucosamine-based composition in a micronized form, optionally in combination with Curcumin. In particular, the present invention relates to N-palmitoyl-D-glucosamine in a micronized or co-micronized form with Curcumin. Such a product can be formulated in human or veterinary pharmaceutical compositions, dietetic products, food supplements, or foods for special medical purposes (FSMP), or in feeds, or nutritional supplements for animals for the treatment of chronic systemic inflammatory diseases, in humans and animals, resulting from dysfunctions of epithelia and synovial membranes.Type: GrantFiled: June 17, 2021Date of Patent: September 5, 2023Assignee: Innovet Italia S.R.L.Inventors: Francesco Della Valle, Maria Federica Della Valle, Gabriele Marcolongo, Sofia Parrasia, Salvatore Cuzzocrea
-
Publication number: 20210308160Abstract: The present invention relates to an N-palmitoyl-D-glucosamine-based composition in a micronized form, optionally in combination with Curcumin. In particular, the present invention relates to N-palmitoyl-D-glucosamine in a micronized or co-micronized form with Curcumin. Such a product can be formulated in human or veterinary pharmaceutical compositions, dietetic products, food supplements, or foods for special medical purposes (FSMP), or in feeds, or nutritional supplements for animals for the treatment of chronic systemic inflammatory diseases, in humans and animals, resulting from dysfunctions of epithelia and synovial membranes.Type: ApplicationFiled: June 17, 2021Publication date: October 7, 2021Applicant: Innovet Italia S.R.L.Inventors: Francesco Della Valle, Maria Federica Della Valle, Gabriele Marcolongo, Sofia Parrasia, Salvatore Cuzzocrea
-
Publication number: 20190290669Abstract: The present invention relates to an N-palmitoyl-D-glucosamine-based composition in a micronized form, optionally in combination with Curcumin. In particular, the present invention relates to N-palmitoyl-D-glucosamine in a micronized or co-micronized form with Curcumin. Such a product can be formulated in human or veterinary pharmaceutical compositions, dietetic products, food supplements, or foods for special medical purposes (FSMP), or in feeds, or nutritional supplements for animals for the treatment of chronic systemic inflammatory diseases, in humans and animals, resulting from dysfunctions of epithelia and synovial membranes.Type: ApplicationFiled: March 20, 2019Publication date: September 26, 2019Applicant: Innovet Italia S.R.L.Inventors: Francesco Della Valle, Maria Federica Della Valle, Gabriele Marcolongo, Sofia Parrasia, Salvatore Cuzzocrea
-
Patent number: 8288361Abstract: The present invention relates to a pharmaceutical composition, for human and veterinary use, that may be used to induce, potentiate and normalise the various phases of the tissue repair process triggered following ulceration and wounding—either involving the loss of matter or not—of neurogenic, vasogenic or traumatic origin, even in cases where the lesions are directly or indirectly associated with underlying systemic pathologies. Particularly, the present invention relates to a pharmaceutical composition comprising an N-acyl derivative of an amino alcohol belonging to the ALIAmides class of molecules, a polyhydroxy alcohol and trans-traumatic acid or a derivative thereof.Type: GrantFiled: April 19, 2006Date of Patent: October 16, 2012Assignee: Innovet Italia S.r.l.Inventors: Francesco Della Valle, Maria Federica Della Valle
-
Patent number: 7244767Abstract: The present invention relates to the use of N-acylvanillinamide derivatives capable of activating the peripheral receptor CB1 of cannabinoids. In particular, the present invention relates to the use of compounds of general formula (I) in which the meanings of R, R1, R3 and Y are as defined in the description, for the preparation of a medicinal product which is capable of activating the peripheral receptor CB1 of cannabinoids.Type: GrantFiled: September 27, 2004Date of Patent: July 17, 2007Assignees: Innovet Italia S.R.L., Consiglio Nazionale Delle RichercheInventors: Tiziana Bisogno, Francesco Della Valle, Luciano De Petrocellis, Vincenzo Di Marzo, Gabriele Marcolongo, Dominique Melck
-
Publication number: 20060257510Abstract: The present invention relates to a pharmaceutical composition, for human and veterinary use, that may be used to induce, potentiate and normalise the various phases of the tissue repair process triggered following ulceration and wounding—either involving the loss of matter or not—of neurogenic, vasogenic or traumatic origin, even in cases where the lesions are directly or indirectly associated with underlying systemic pathologies. Particularly, the present invention relates to a pharmaceutical composition comprising an N-acyl derivative of an amino alcohol belonging to the ALIAmides class of molecules, a polyhydroxy alcohol and trans-traumatic acid or a derivative thereof.Type: ApplicationFiled: April 19, 2006Publication date: November 16, 2006Applicant: INNOVET ITALIA S.r.l.Inventors: Francesco Della Valle, Maria Della Valle
-
Publication number: 20050065216Abstract: The present invention relates to the use of N-acylvanillinamide derivatives capable of activating the peripheral receptor CB1 of cannabinoids. In particular, the present invention relates to the use of compounds of general formula (I) in which the meanings of R, R1, R3 and Y are as defined in the description, for the preparation of a medicinal product which is capable of activating the peripheral receptor CB1 of cannabinoids.Type: ApplicationFiled: September 27, 2004Publication date: March 24, 2005Applicants: Innovet Italia S.R.L., Consiglio Nazionale Delle RicercheInventors: Tiziana Bisogno, Francesco Della Valle, Luciano De Petrocellis, Vincenzo Di Marzo, Gabriele Marcolongo, Dominique Melck
-
Patent number: 6864285Abstract: The present invention relates to novel covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids with aminoalcohols of general formula (I) which can usefully be used as agonists of the CB2 cannabinoid receptor and hence as drugs active in pathological conditions which can be controlled by stimulation and/or costimulation of this receptorType: GrantFiled: July 7, 1999Date of Patent: March 8, 2005Assignee: Innovet Italia S.r.l.Inventors: Cristina Comelli, Francesco Della Valle, Maria Federica Della Valle, Gabriele Marcolongo
-
Patent number: 6548550Abstract: The present invention relates to a method for treating eosinophilic granuloma in a Feline comprising administering a pharmaceutical composition, the composition comprising N-palmitoylethanolamide. The present invention also relates to said pharmaceutical composition and the process for the preparation thereof.Type: GrantFiled: January 4, 2002Date of Patent: April 15, 2003Assignee: Innovet Italia S.r.l.Inventors: Cristina Comelli, Maria Federica Della Valle, Francesco Della Valle, Gabriele Marcolongo